Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
DALLAS, June 19 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by...
CHICAGO, Jan. 31 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
AtheroGenics, Inc. (Nasdaq:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief...
Invitrogen and Leap Wireless Secure Top 100 Rankings SAN DIEGO, Aug. 2 /PRNewswire/ -- Mentus, a San Diego-based integrated marketing communications and design agency, announced today that the...
AtheroGenics Inc (NASDAQ: AGIX) announces the following Webcast: ? What: AtheroGenics Inc Second Quarter 2006 Earnings Conference Call Webcast ? When: July 20, 2006 @ 09:00 AM Eastern ? Where:...
AtheroGenics Inc (NASDAQ: AGIX) announces the following Webcast: ? What: AtheroGenics Inc First Quarter 2006 Earnings Conference Call Webcast ? When: April 20, 2006 @ 09:00 AM Eastern ? Where:...
ATLANTA, March 28 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Walker...
ATLANTA, March 2 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M...
ATLANTA, Feb. 28 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.13 | -0.44812133747 | 29.01 | 29.74 | 28.2 | 11098 | 28.8816355 | SP |
| 4 | -0.92 | -3.08724832215 | 29.8 | 30.37 | 28.2 | 10924 | 29.21692982 | SP |
| 12 | 2.21 | 8.28646419198 | 26.67 | 30.37 | 25.77 | 7059 | 28.59691824 | SP |
| 26 | 3.52 | 13.880126183 | 25.36 | 30.37 | 21.82 | 5861 | 26.79528143 | SP |
| 52 | 3.52 | 13.880126183 | 25.36 | 30.37 | 21.82 | 5861 | 26.79528143 | SP |
| 156 | 3.52 | 13.880126183 | 25.36 | 30.37 | 21.82 | 5861 | 26.79528143 | SP |
| 260 | 3.52 | 13.880126183 | 25.36 | 30.37 | 21.82 | 5861 | 26.79528143 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
